Ashiq Mubarack

Stock Analyst at Citigroup

(0)
# 4708
Out of 5,317 analysts
3
Total ratings
33.33%
Success rate
-24.43%
Average return
Main Sectors:
Top Industries:
2 Stocks
Name Action Price Target Current % Upside Ratings Updated
MRSN Mersana Therapeutics
Maintains: Buy
6 5
0.33 1415.15% 2 Aug 27, 2024
DRTS Alpha Tau Medical
Initiates Coverage On: Buy
8
2.54 214.96% 1 Dec 15, 2023